Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist

被引:49
作者
Lundkvist, J
Sundgren-Andersson, AK
Tingsborg, S
Östlund, P
Engfors, C
Alheim, K
Bartfai, T
Iverfeldt, K
Schultzberg, M [1 ]
机构
[1] Novum, Dept Clin Neurosci & Family Med, Div Geriatr Med, S-14186 Huddinge, Sweden
[2] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Neurochem & Neurotoxicol, S-10691 Stockholm, Sweden
关键词
glial fibrillary acidic protein promoter; lipopolysaccharide; interleukin-1; cytokine;
D O I
10.1152/ajpregu.1999.276.3.R644
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
The interleukin-1 (IL-1) receptor antagonist (IL-1ra) is an endogenous antagonist that blocks the effects of the proinflammatory cytokines IL-1 alpha and IL-1 beta by occupying the type I IL-1 receptor. Here we describe transgenic mice with astrocyte-direeted overexpression of the human secreted IL-1ra (hsIL-1ra) under the control of the murine glial fibrillary acidic protein (GFAP) promoter. Two GFAP-hsIL-1ra strains have been generated and characterized further: GILRA2 and GILRA4. These strains show a brain-specific expression of the hsIL-1ra at the mRNA and protein levels. The hsIL-1ra protein was approximated to similar to 50 ng/brain in cytosolic fractions of whole brain homogenates, with no differences between male and female mice or between the two strains. Furthermore, the protein is secreted, inasmuch as the concentration of hsIL-1ra in the cerebrospinal fluid was 13 (GILRA2) to 28 (GILRA4) times higher in the transgenic mice than in the control animals. To characterize the transgenic phenotype, GILRA mice and nontransgenic controls were injected with recombinant human IL-1 beta (central injection) or lipopolysaccharide (LPS, peripheral injection). The febrile response elicited by IL-1 beta (50 ng/mouse icv) was abolished in hsIL-1ra-overexpressing animals, suggesting that the central IL-1 receptors were occupied by antagonist. The peripheral LPS injection (25 mu g/kg ip) triggered a fever in overexpressing and control animals. Moreover, no differences were found in LPS-induced (100 and 1,000 mu g/kg ip; 1 and 6 h after injection) IL-1 beta and IL-6 serum levels between GILRA and wild-type mice. On the basis of these results, we suggest that binding of central IL-1 to central IL-1 receptors is not important in LPS-induced fever or LPS-induced IL-1 beta and IL-6 plasma levels.
引用
收藏
页码:R644 / R651
页数:8
相关论文
共 39 条
[1]   Hyperresponsive febrile reactions to interleukin (IL) 1 alpha and IL-1 beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1 beta-deficient mice [J].
Alheim, K ;
Chai, Z ;
Fantuzzi, G ;
Hasanvan, H ;
Malinowsky, D ;
DiSanto, E ;
Ghezzi, P ;
Dinarello, CA ;
Bartfai, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2681-2686
[2]   NUCLEOTIDE-SEQUENCE OF HUMAN MONOCYTE INTERLEUKIN-1 PRECURSOR CDNA [J].
AURON, PE ;
WEBB, AC ;
ROSENWASSER, LJ ;
MUCCI, SF ;
RICH, A ;
WOLFF, SM ;
DINARELLO, CA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (24) :7907-7911
[3]   NEUROLOGIC DISEASE INDUCED IN TRANSGENIC MICE BY CEREBRAL OVEREXPRESSION OF INTERLEUKIN-6 [J].
CAMPBELL, IL ;
ABRAHAM, CR ;
MASLIAH, E ;
KEMPER, P ;
INGLIS, JD ;
OLDSTONE, MBA ;
MUCKE, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10061-10065
[4]   Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipolysaccharide or IL-1 beta: A study on IL-6-deficient mice [J].
Chai, Z ;
Gatti, S ;
Toniatti, C ;
Poli, V ;
Bartfai, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (01) :311-316
[5]  
DANTZER R, 1992, PERG S NEUR, V5, P135
[6]  
DIANA A, IN PRESS NEUROSCIENC
[7]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147
[8]   SIMILARITY BETWEEN THE INTERLEUKIN-1 RECEPTORS ON A MURINE T-LYMPHOMA CELL-LINE AND ON A MURINE FIBROBLAST CELL-LINE [J].
DOWER, SK ;
CALL, SM ;
GILLIS, S ;
URDAL, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (04) :1060-1064
[9]  
DRIPPS DJ, 1991, J BIOL CHEM, V266, P10331
[10]   PRIMARY STRUCTURE AND FUNCTIONAL EXPRESSION FROM COMPLEMENTARY-DNA OF A HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
EISENBERG, SP ;
EVANS, RJ ;
AREND, WP ;
VERDERBER, E ;
BREWER, MT ;
HANNUM, CH ;
THOMPSON, RC .
NATURE, 1990, 343 (6256) :341-346